Bruce Akright
Gynecology · Schertz, TXNPI 1679515373
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,408 and has fallen 80.7% since, to $271 in 2023.
Across 139 payments — averaging $22.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$604
- Amgen$419
- Daiichi Sankyo Inc.$300
- Pfizer$206
- Astellas Pharma US Inc$158
- Intuitive Surgical$140
- plus $1K from 22 others
Across 3 payments — averaging $10,964 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mitsubishi Tanabe Pharma Development America, Inc.$33K
What the payments were for
- Food & beverage$3,09697%
- Education$963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $604 |
| Amgen | 10 | $419 |
| Daiichi Sankyo Inc. | 15 | $300 |
| Pfizer | 15 | $206 |
| Astellas Pharma US Inc | 6 | $158 |
| Intuitive Surgical | 2 | $140 |
| Radius Health, Inc. | 2 | $139 |
| Novo Nordisk | 2 | $130 |
| Regeneron | 1 | $123 |
| AstraZeneca | 1 | $114 |
| Exeltis, USA Inc. | 5 | $102 |
| Mylan Pharmaceuticals Inc. | 7 | $101 |
| Organon | 7 | $83 |
| Merck | 5 | $76 |
| Coopersurgical, Inc. | 3 | $70 |
| Mayne Pharma Commercial LLC | 3 | $69 |
| Hologic Sales And Service, LLC | 2 | $54 |
| Duchesnay USA Incorporated | 3 | $47 |
| Therapeuticsmd, Inc. | 3 | $42 |
| Agile Therapeutics, Inc. | 2 | $32 |
| Vertical Pharmaceuticals, LLC | 2 | $31 |
| Johnson & Johnson | 1 | $30 |
| Millicent US Inc | 2 | $27 |
| Avion Pharmaceuticals | 2 | $25 |
| Bayer | 1 | $24 |
| Scynexis, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,192 in reported general payments places this provider in the 75th percentile of 161 gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $970 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Schertz
- Randall SadlerSchertz$4K
- Richard FarnamEl Paso$1.2M
- Jessica ShepherdDallas$809K
- Linda LacyEl Paso$627K
- John WhitfieldFort Worth$141K
- Robert ZurawinHouston$61K
- Charles EubankCorpus Christi$51K
- Tiffany JacksonGarland$50K
- Cynthia Chaparro-KruegerAustin$41K
- Laura SheltonCorpus Christi$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.